Clinical significance of serum fibroblast growth factor 23 as a surrogate marker of the cardiorenal hemodynamic state in patients with heart failure

被引:0
作者
Imazu, M. [1 ]
Takahama, H. [1 ]
Asanuma, H. [2 ]
Funada, A. [1 ]
Ohara, T. [1 ]
Hasegawa, T. [1 ]
Asakura, M. [1 ]
Kanzaki, H. [1 ]
Anzai, T. [1 ]
Kitakaze, M. [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Cardiovasc Med, Suita, Osaka, Japan
[2] Kyoto Prefectural Univ Med, Kyoto, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:781 / 782
页数:2
相关论文
共 50 条
[21]   Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure [J].
Isakova, Tamara ;
Houston, Jessica ;
Santacruz, Laura ;
Schiavenato, Eva ;
Somarriba, Gabriel ;
Harmon, William G. ;
Lipshultz, Steven E. ;
Miller, Tracie L. ;
Rusconi, Paolo G. .
PEDIATRIC NEPHROLOGY, 2013, 28 (10) :2035-2042
[22]   Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction [J].
Ghuman, Jasleen ;
Cai, Xuan ;
Patel, Ravi B. ;
Khan, Sadiya S. ;
Hecktman, Jonathan ;
Redfield, Margaret M. ;
Lewis, Gregory ;
Shah, Sanjiv J. ;
Wolf, Myles ;
Isakova, Tamara ;
Mehta, Rupal .
JOURNAL OF CARDIAC FAILURE, 2021, 27 (03) :309-317
[23]   Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure [J].
Tamara Isakova ;
Jessica Houston ;
Laura Santacruz ;
Eva Schiavenato ;
Gabriel Somarriba ;
William G. Harmon ;
Steven E. Lipshultz ;
Tracie L. Miller ;
Paolo G. Rusconi .
Pediatric Nephrology, 2013, 28 :2035-2042
[24]   Fibroblast growth factor 23 is associated with disease severity and prognosis in chronic heart failure [J].
Kliebhan, J. ;
Trenkler, C. ;
Wuertinger, P. ;
Seger, C. ;
Kaser, S. ;
Mayer, G. ;
Pirklbauer, M. ;
Ulmer, H. ;
Griesmacher, A. .
WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 :S120-S120
[25]   Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction [J].
Fan, Liuzhang ;
Gu, Lingyun ;
Yao, Yuyu ;
Ma, Genshan .
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
[26]   Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery [J].
Hofer, Felix ;
Hammer, Andreas ;
Pailer, Ulrike ;
Koller, Lorenz ;
Kazem, Niema ;
Steinacher, Eva ;
Steinlechner, Barbara ;
Andreas, Martin ;
Laufer, Guenther ;
Wojta, Johann ;
Zelniker, Thomas A. ;
Hengstenberg, Christian ;
Niessner, Alexander ;
Sulzgruber, Patrick .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (05)
[27]   Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction [J].
Koller, Lorenz ;
Kleber, Marcus E. ;
Brandenburg, Vincent M. ;
Goliasch, Georg ;
Richter, Bernhard ;
Sulzgruber, Patrick ;
Scharnagl, Hubert ;
Silbernagel, Guenther ;
Grammer, Tanja B. ;
Delgado, Graciela ;
Tomaschitz, Andreas ;
Pilz, Stefan ;
Berger, Rudolf ;
Moertl, Deddo ;
Huelsmann, Martin ;
Pacher, Richard ;
Maerz, Winfried ;
Niessner, Alexander .
CIRCULATION-HEART FAILURE, 2015, 8 (06) :1059-1067
[28]   Relationship between Indoxyl Sulfate and Fibroblast Growth Factor 23 in Heart Failure Patients with Preserved Renal Function [J].
Imazu, Miki ;
Asakura, Masanori ;
Takahama, Hiroyuki ;
Asanuma, Hiroshi ;
Funada, Akira ;
Sugano, Yasuo ;
Ohara, Takahiro ;
Hasegawa, Takuya ;
Kanzaki, Hideaki ;
Anzai, Toshihisa ;
Kitakaze, Masafumi .
JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) :S207-S207
[29]   Fibroblast growth factor 23 is an independent and specific predictor of mortality in patients with heart failure and reduced ejection fraction [J].
Koller, L. ;
Kleber, M. E. ;
Brandenburg, V. M. ;
Goliasch, G. ;
Scharnagl, H. ;
Grammer, T. B. ;
Tomaschitz, A. ;
Huelsmann, M. ;
Maerz, W. ;
Niessner, A. .
EUROPEAN HEART JOURNAL, 2015, 36 :1201-1201
[30]   Serum fibroblast growth factor-23 levels in chronic haemodialysis patients [J].
Ibrahim, Salwa ;
Rashed, Laila .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (01) :163-169